Heart Rhythm
Volume 6, Issue 10 , Pages 1439-1447 , October 2009

Upgrade and de novo cardiac resynchronization therapy: Impact of paced or intrinsic QRS morphology on outcomes and survival

Received 29 March 2009 ,Accepted 6 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Wokhlu has received travel support from Medtronic, Boston Scientific, and St. Jude Medical to attend educational seminars. Dr. Hayes is an educational speaker and serves on the advisory boards for Medtronic, Boston Scientific, Sorin Medical Group, and St. Jude Medical, and he is a member of the steering committee for St. Jude Medical. Dr. Asirvatham receives honoraria and is on the speaker's board for St. Jude Medical, Boston Scientific, and Medtronic. In addition, he is a co-patent holder for an alternative resynchronization therapy technique. Ms. Webster is on an advisory board for Boston Scientific.

PII: S1547-5271(09)00748-6

doi: 10.1016/j.hrthm.2009.07.009

Heart Rhythm
Volume 6, Issue 10 , Pages 1439-1447 , October 2009

Article Tools

* Image Usage & Resolution